Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FZD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC107984534 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPINK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAN1B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR1E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMIGO3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUTM2B-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1orf131 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOLC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXSM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCMBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNPC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEPRO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NIFK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC19A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EBLN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP1A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on